Kura Continues Araxes Legacy With New Menin And FTI Focuses In Cancer

 
• By Ayisha Sharma

Emerging Company Profile: The US biotech is advancing a pipeline of precision medicines targeting menin and farnesyltransferase for liquid and solid tumors, respectively, building on the work of two pioneering companies in the KRAS space.  

Emerging Company Profile: Kura Oncology
Kura Takes Its Name From A River In The Caucasus Region • Source: Shutterstock

More from Emerging Company Profiles

More from Start-Ups & SMEs